Loading chat...

NJ A1526

Bill

Status

Introduced

1/9/2024

Primary Sponsor

Gerard Scharfenberger

Click for details

Origin

General Assembly

2024-2025 Regular Session

AI Summary

  • Classifies xylazine and its various compounds as a Schedule III controlled dangerous substance in New Jersey, with an exemption for veterinarians using it in the professional practice of veterinary medicine

  • Makes illegal manufacture, distribution, or dispensing of xylazine a third-degree crime punishable by 3-5 years imprisonment and fines up to $25,000

  • Establishes possession, use, or being under the influence of xylazine as a third-degree crime with fines up to $35,000

  • Provides enhanced penalties for xylazine offenses committed within 1,000 feet of school property, within 500 feet of certain public spaces, or when distributed to minors or pregnant persons

  • Directs the Director of the Division of Consumer Affairs to promulgate rules and regulations to implement the new classification

Legislative Description

Classifies xylazine as Schedule III controlled dangerous substance under certain circumstances.

Judiciary

Last Action

Introduced, Referred to Assembly Judiciary Committee

1/9/2024

Committee Referrals

Judiciary1/9/2024

Full Bill Text

No bill text available